Algorithmic Biologics secures seed funding from Axilor Lab


Algorithmic Biologics Pvt Ltd (ABPL), a deep-tech startup building algorithms for molecular programming, today announced that it has received an undisclosed amount of seed funding from Axilor Lab.

ABPL’s platform technology works as compression algorithm for molecular testing and has applications in healthcare, pharmaceuticals, agriculture, animal husbandry, food safety, synthetic biology, and molecular biology research.

Speaking on the funding, Dr. Tarun Khanna, Harvard Business School professor & co-founder of Axilor said, “Creating and curating ventures requires innate talent to come up with an idea, creativity to demonstrate product-market-fit, and operating skill to scale the effort.  Throughout, we need capital. At Axilor Labs, all of these ingredients come together to bring cutting-edge scientific ideas into India’s mainstream.” 

- Sponsored-

“Our investment in Algorithmic exemplifies this approach. Together with Manoj, we are helping prove the business impact of this breakthrough technology.,” He added.

Commenting on the fundraise, Dr. Manoj Gopalkrishnan, professor at IIT Bombay & Founder of ABPL said, “We are pursuing our vision of smarter molecular testing leading to better health for all. We are deeply invested in science and technology, and are bringing cutting-edge ideas from molecular computing and computer science to molecular testing.”


Stay Informed With TechGraph

Let us bring the most important stories of the day to your inbox.

Krishna Mali
Krishna Mali
Founder & Editor of TechGraph

Latest Stories

Related Articles